Update on the Management of Infantile-Onset Pompe Disease

In this review:

The benefits of enzyme replacement therapy

Start ERT early
Unmet medical needs remain
Clinical efficacy of ERT in infantile-onset Pompe disease
Recombinant human acid á–glucosidase: major clinical benefits in infantile o

Please login below to download this issue (PDF)